Impaired diffusing capacity for carbon monoxide is common in critically ill Covid-19 patients at four months post-discharge
Ekbom E, Frithiof R, Emilsson Öi, Larson Im, Lipcsey M, Rubertsson S, Wallin E, Janson C, Hultström M, Malinovschi A, Ekbom E, Frithiof R, Emilsson Öi, Larson Im, Lipcsey M, Rubertsson S, Wallin E, Janson C, Hultström M, Malinovschi A
Abstract
There is limited knowledge about the long-term effects on pulmonary function of COVID-19 in patients that required intensive care treatment. Spirometry and diffusing capacity for carbon monoxide (DLCO) were measured in 60 subjects at 3-6 months post discharge. Impaired lung function was found in 52% of the subjects, with reduced DLCO as the main finding. The risk increased with age above 60 years, need for mechanical ventilation and longer ICU stay as well as lower levels of C-reactive protein at admission. This suggests the need of follow-up with pulmonary function testing in intensive-care treated patients.
Keywords: ARDS; COVID-19; Diffusion capacity; Follow up; ICU treatment; Lung function.
Copyright © 2021 The Authors. Published by Elsevier Ltd.. All rights reserved.
References
- Carfì A., Bernabei R., Landi F. Persistent symptoms in patients after acute COVID-19. J. Am. Med. Assoc. 2020;324:603–605.
- Herridge M.S., et al. Functional disability 5 Years after acute respiratory distress syndrome. N. Engl. J. Med. 2011;364:1293–1304.
- Mo X., et al. Abnormal pulmonary function in COVID-19 patients at time of hospital discharge. Eur. Respir. J. 2020;55
- Huang Y., et al. Impact of coronavirus disease 2019 on pulmonary function in early convalescence phase. Respir. Res. 2020;21:163. 163.
- Zhao Y.-M., et al. Follow-up study of the pulmonary function and related physiological characteristics of COVID-19 survivors three months after recovery. EClinicalMedicine. 2020;25:100463. 100463.
- Frija-Masson J., et al. Functional characteristics of patients with SARS-CoV-2 pneumonia at 30 days post-infection. Eur. Respir. J. 2020;56
- Raman B., et al. Medium-term effects of SARS-CoV-2 infection on multiple vital organs, exercise capacity, cognition, quality of life and mental health, post-hospital discharge. medRxiv 2020.10.15. 2020:20205054. doi: 10.1101/2020.10.15.20205054.
- Hui D.S., et al. Impact of severe acute respiratory syndrome (SARS) on pulmonary function, functional capacity and quality of life in a cohort of survivors. Thorax. 2005;60:401.
- Zhang P., et al. Long-term bone and lung consequences associated with hospital-acquired severe acute respiratory syndrome: a 15-year follow-up from a prospective cohort study. Bone Res. 2020;8 8.
- Park W.B., et al. Correlation between pneumonia severity and pulmonary complications in Middle East respiratory syndrome. J. Kor. Med. Sci. 2018;33:e169. e169.
Source: PubMed